New shot aims to tame BK virus in kidney transplant patients
NCT ID NCT07503561
First seen Apr 03, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study tests a new drug called AIC263029 in adult kidney transplant patients who have a BK virus infection in their blood. The goal is to see if the drug is safe and can lower virus levels. Participants will receive weekly injections for 4 weeks and be monitored for about 24 weeks. The study compares the drug to a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BK VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.